Dr. Chun is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
15 York St
New Haven, CT 06510Phone+1 203-737-6389Fax+1 203-737-6118
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Cardiovascular Disease, 2004 - 2009
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2002 - 2005
- Johns Hopkins University School of MedicineClass of 2002
Certifications & Licensure
- CA State Medical License 2004 - Present
- CT State Medical License 2009 - 2025
- American Board of Internal Medicine Cardiovascular Disease
Clinical Trials
- Tofacitinib for Treatment of Moderate COVID-19 Start of enrollment: 2020 Oct 14
- IRAK4 Inhibition in Treatment of COVID-19 With ARDS (I-RAMIC) Start of enrollment: 2020 Nov 27
Publications & Presentations
PubMed
- 11 citationsBMPR1A promotes ID2-ZEB1 interaction to suppress excessive endothelial to mesenchymal transition.Heon-Woo Lee, Takaomi Adachi, Boryeong Pak, Saejeong Park, Xiaoyue Hu
Cardiovascular Research. 2023-05-02 - 6 citationsProteomic profiling demonstrates inflammatory and endotheliopathy signatures associated with impaired cardiopulmonary exercise hemodynamic profile in Post Acute Sequel...Inderjit Singh, Brooks P Leitner, Yiwei Wang, Hanming Zhang, Phillip Joseph
Pulmonary Circulation. 2023-04-01 - 29 citationsLncRNA Airn alleviates diabetic cardiac fibrosis by inhibiting activation of cardiac fibroblasts via a m6A-IMP2-p53 axis.Tingwei Peng, Mingchuan Liu, Lang Hu, Dong Guo, Di Wang
Biology Direct. 2022-11-16
Press Mentions
- Breakthrough COVID-19 Cases Have Become More Common, Underscoring Need for Boosters, Yale Study FindsDecember 4th, 2021
- Serious Breakthrough COVID-19 Cases Bring Urgency to BoostersDecember 4th, 2021
- Severe Breakthrough COVID-19 Cases Drive Urgency of BoostersDecember 3rd, 2021
- Join now to see all
Grant Support
- Role Of Apelin In The Systemic And Pulmonary VasculatureNational Heart, Lung, And Blood Institute2009–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: